Terms: = Lymphoma AND NOTCH1, TAN1, P46531, 4851, ENSG00000148400, hN1 AND Prognosis
120 results:
1. Integrated analysis of transcriptome and genome variations in pediatric T cell acute lymphoblastic leukemia: data from north Indian tertiary care center.
Singh M; Sharma P; Bhatia P; Trehan A; Thakur R; Sreedharanunni S
BMC Cancer; 2024 Mar; 24(1):325. PubMed ID: 38459434
[TBL] [Abstract] [Full Text] [Related]
2. [Clinical and molecular biological characterization of patients with accelerated chronic lymphocytic leukemia].
Zhou ZY; Dai LMJ; Sha YQ; Qiu TL; Qin SC; Miao Y; Xia Y; Wu W; Tang HN; Xu W; Li JY; Zhu HY
Zhonghua Xue Ye Xue Za Zhi; 2023 Nov; 44(11):917-923. PubMed ID: 38185521
[No Abstract] [Full Text] [Related]
3.
Choi YJ; Min YK; Lee ST; Choi JR; Shin S
Ann Lab Med; 2024 Jul; 44(4):335-342. PubMed ID: 38145892
[TBL] [Abstract] [Full Text] [Related]
4. Genomic Profiling of Primary Diffuse Large B-Cell lymphoma of the Central Nervous System Suggests Novel Potential Therapeutic Targets.
Agostinelli C; Morandi L; Righi S; Cirillo L; Iommi M; Tonon C; Mazzatenta D; Zoli M; Rossi M; Bagnato G; Broccoli A; Lodi R; Zinzani PL; Sabattini E; Giannini C; Asioli S
Mod Pathol; 2023 Dec; 36(12):100323. PubMed ID: 37678673
[TBL] [Abstract] [Full Text] [Related]
5. Anlotinib exerts an anti-T-cell acute lymphoblastic leukemia effect in vitro and in vivo.
Zhang X; Geng L; Yang L; Wang Y; Zou Z; Zhang Y; Xu H; Lei H; Cao Y; Wu Y; Gu W; Zhou L
Cell Signal; 2023 Oct; 110():110837. PubMed ID: 37544636
[TBL] [Abstract] [Full Text] [Related]
6. Characteristics of Molecular Genetic Mutations and Their Correlation with prognosis in Adolescent and Adult Patients with Acute Lymphoblastic Leukemia.
Sun X; Liu X; Li Y; Shi X; Li Y; Tan R; Jiang Y; Sui X; Ge X; Xu H; Wang X; Fang X
Oncology; 2024; 102(1):85-98. PubMed ID: 37437551
[TBL] [Abstract] [Full Text] [Related]
7. Outlier Expression of Isoforms by Targeted or Total RNA Sequencing Identifies Clinically Significant Genomic Variants in Hematolymphoid Tumors.
Tsai HK; Gogakos T; Lip V; Tsai JM; Li YD; Fisch AS; Weiss J; Yang W; Grimmett L; DiToro D; Schaefer EJ; Lindsley RC; Tran TH; Caron M; Langlois S; Sinnett D; Pikman Y; Nardi V; Kim AS; Silverman LB; Harris MH
J Mol Diagn; 2023 Sep; 25(9):665-681. PubMed ID: 37419244
[TBL] [Abstract] [Full Text] [Related]
8. Targeted therapy and immunotherapy for T cell acute lymphoblastic leukemia/lymphoma.
Huang YH; Wan CL; Dai HP; Xue SL
Ann Hematol; 2023 Aug; 102(8):2001-2013. PubMed ID: 37227492
[TBL] [Abstract] [Full Text] [Related]
9. Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma.
Shen R; Fu D; Dong L; Zhang MC; Shi Q; Shi ZY; Cheng S; Wang L; Xu PP; Zhao WL
Signal Transduct Target Ther; 2023 Apr; 8(1):145. PubMed ID: 37032379
[TBL] [Abstract] [Full Text] [Related]
10. Noninvasive genomic profiling of somatic mutations in oral cavity cancers.
Xi Y; Negrao MV; Akagi K; Xiao W; Jiang B; Warner SC; Dunn JD; Wang J; Symer DE; Gillison ML
Oral Oncol; 2023 May; 140():106372. PubMed ID: 37004423
[TBL] [Abstract] [Full Text] [Related]
11. [Clinical Study on the Relationship between Gene Mutation Profile and prognosis in Pediatric Acute Lymphocyte Leukemia].
Chen Y; Qi SS; Ding LL; DU Y; Song N; Wang Z; Yang L; Sun M; Xiong H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Feb; 31(1):17-24. PubMed ID: 36765471
[TBL] [Abstract] [Full Text] [Related]
12. Heterogeneity of B cell lymphopoiesis in patients with premalignant and active myeloma.
Jakubikova J; Cholujova D; Beke G; Hideshima T; Klucar L; Leiba M; Jamroziak K; Richardson PG; Kastritis E; Dorfman DM; Anderson KC
JCI Insight; 2023 Feb; 8(3):. PubMed ID: 36752202
[TBL] [Abstract] [Full Text] [Related]
13. Spectrum and clinical features of gene mutations in Chinese pediatric acute lymphoblastic leukemia.
Shen D; Liu L; Xu X; Song H; Zhang J; Xu W; Zhao F; Liang J; Liao C; Wang Y; Xia T; Wang C; Lou F; Cao S; Qin J; Tang Y
BMC Pediatr; 2023 Feb; 23(1):62. PubMed ID: 36739388
[TBL] [Abstract] [Full Text] [Related]
14. [Clonality relatedness and molecular characteristics of Richter transformation].
Sha YQ; Jiang R; Miao Y; Qiu TL; Qin SC; Qiu JY; Mi HL; Wu W; Qiao C; Wu YJ; Xia Y; Wang L; Fan L; Xu W; Li JY; Zhu HY
Zhonghua Xue Ye Xue Za Zhi; 2022 Oct; 43(10):841-847. PubMed ID: 36709198
[No Abstract] [Full Text] [Related]
15. Notch Partners in the Long Journey of T-ALL Pathogenesis.
Toribio ML; González-García S
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674902
[TBL] [Abstract] [Full Text] [Related]
16. Exploring the pharmacological mechanisms of Shuanghuanglian against T-cell acute lymphoblastic leukaemia through network pharmacology combined with molecular docking and experimental validation.
Yang Y; Yang Y; Shen Y; Liu J; Zeng Y; Wei C; Liu C; Pan Y; Guo Q; Zhong F; Guo L; Liu W
Pharm Biol; 2023 Dec; 61(1):259-270. PubMed ID: 36656546
[TBL] [Abstract] [Full Text] [Related]
17. PD-1 signalling defines and protects leukaemic stem cells from T cell receptor-induced cell death in T cell acute lymphoblastic leukaemia.
Xu X; Zhang W; Xuan L; Yu Y; Zheng W; Tao F; Nemechek J; He C; Ma W; Han X; Xie S; Zhao M; Wang J; Qu Y; Liu Q; Perry JM; Jiang L; Zhao M
Nat Cell Biol; 2023 Jan; 25(1):170-182. PubMed ID: 36624186
[TBL] [Abstract] [Full Text] [Related]
18. The evaluation of gene mutation profiles by next-generation sequencing in diffuse large B-cell lymphoma.
Özçalımlı A; Erdoğdu İH; Turgutkaya A; Yavaşoğlu İ; Döger FK; Bolaman AZ
Int J Lab Hematol; 2023 Jun; 45(3):310-316. PubMed ID: 36576110
[TBL] [Abstract] [Full Text] [Related]
19. Richter transformation in Chronic Lymphocytic Leukemia.
Innocenti I; Benintende G; Tomasso A; Fresa A; Autore F; Larocca LM; Laurenti L
Hematol Oncol; 2023 Aug; 41(3):293-300. PubMed ID: 36433773
[TBL] [Abstract] [Full Text] [Related]
20. Mutational profiling of circulating tumor DNA and clinical characteristics in lymphoma: Based on next generation sequencing.
Hou Y; Zi J; Liu S; Ge Q; Ge Z
Mol Carcinog; 2023 Feb; 62(2):200-209. PubMed ID: 36300887
[TBL] [Abstract] [Full Text] [Related]
[Next]